{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T02:50:32Z","timestamp":1777431032645,"version":"3.51.4"},"reference-count":44,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2006,1,1]],"date-time":"2006-01-01T00:00:00Z","timestamp":1136073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2006,1]]},"DOI":"10.1002\/jps.20516","type":"journal-article","created":{"date-parts":[[2005,11,28]],"date-time":"2005-11-28T21:16:51Z","timestamp":1133212611000},"page":"207-224","source":"Crossref","is-referenced-by-count":9,"title":["Mediastinal node and diaphragmatic targeting after intracavitary injection of avidin\/99mTc-blue-biotin-liposome system"],"prefix":"10.1016","volume":"95","author":[{"given":"Luis A.","family":"Medina","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergio M.","family":"Calixto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Klipper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William T.","family":"Phillips","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beth","family":"Goins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1002\/jps.20516_bb0010","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0169-409X(01)00154-5","article-title":"Liposomes to target the lymphatic by subcutaneous administration","volume":"50","author":"Oussoren","year":"2001","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1002\/jps.20516_bb0015","first-page":"57","article-title":"Drug delivery to lymphatic tissue","volume":"13","author":"Papisov","year":"1996","journal-title":"Crit Rev Ther Drug Carrier Syst"},{"key":"10.1002\/jps.20516_bb0020","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/BF01664869","article-title":"Bacteria, toxin, and peritoneum","volume":"14","author":"Hau","year":"1990","journal-title":"World J Surg"},{"key":"10.1002\/jps.20516_bb0025","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0301-2115(99)00275-4","article-title":"Mediastinal metastasis of ovarian carcinoma","volume":"91","author":"Montero","year":"2000","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1002\/jps.20516_bb0030","first-page":"37","article-title":"Lymph node metastasis and surgical management of gastric cancer invading esophagus","volume":"42","author":"Yonemura","year":"1995","journal-title":"Hepatogastroenterology"},{"key":"10.1002\/jps.20516_bb0035","first-page":"453","article-title":"The role of the diaphragm in lymphatic absorption from the peritoneal cavity","volume":"186","author":"Abu-Hijleh","year":"1995","journal-title":"J Anat"},{"key":"10.1002\/jps.20516_bb0040","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/aja.1001800209","article-title":"Light and electron microscope observations of the lymphatic drainage units of the peritoneal cavity of roedents","volume":"180","author":"Tsilibary","year":"1987","journal-title":"Am J Anat"},{"key":"10.1002\/jps.20516_bb0045","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/bjc.1991.92","article-title":"Therapy of human ovarian cancer xenografts with intraperitoneal liposome encapsulated muramyl-tripeptide phosphoethanolamine (MTP-PE) and recombinant GM-CSF","volume":"63","author":"Malik","year":"1991","journal-title":"Br J Cancer"},{"key":"10.1002\/jps.20516_bb0050","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/(SICI)1097-0215(19970328)71:1<103::AID-IJC17>3.0.CO;2-J","article-title":"Activity of paclitaxel liposome formulations against human ovarian tumor xenografts","volume":"71","author":"Sharma","year":"1997","journal-title":"Int J Cancer"},{"key":"10.1002\/jps.20516_bb0055","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/0304-3835(96)04380-7","article-title":"Paclitaxel-liposomes for intracavitary therapy of intraperitoneal P388 leukemia","volume":"107","author":"Sharma","year":"1996","journal-title":"Cancer Lett"},{"key":"10.1002\/jps.20516_bb0060","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/BF00689964","article-title":"Pharmacokinetics of liposome-entrapped cis-bis-neodecanoato-trans-R,R-1,2-diaminocyclohexane platinium (II) and cisplatin given i.v. and i.p. in the rat","volume":"30","author":"Vadiei","year":"1992","journal-title":"Can Chem Pharm"},{"key":"10.1002\/jps.20516_bb0065","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/nrd1632","article-title":"Recent advances with liposomes as pharmaceutical carriers","volume":"4","author":"Torchilin","year":"2005","journal-title":"Nat Rev Drug Discov"},{"key":"10.1002\/jps.20516_bb0070","doi-asserted-by":"crossref","first-page":"747","DOI":"10.2165\/00003495-199856050-00001","article-title":"Liposomal drug formulations rationale for development and what we can expect for the future","volume":"56","author":"Allen","year":"1998","journal-title":"Drugs"},{"key":"10.1002\/jps.20516_bb0075","series-title":"Vesicles","first-page":"447","article-title":"Liposomes in drug delivery","author":"Lasic","year":"1996"},{"key":"10.1002\/jps.20516_bb0080","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1126\/science.1095833","article-title":"Drug delivery systems: Entering the mainstream","volume":"53","author":"Allen","year":"2004","journal-title":"Science"},{"key":"10.1002\/jps.20516_bb0085","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1124\/jpet.102.037119","article-title":"A novel approach for the increased delivery of pharmaceutical agents to the peritoneum and associated lymph nodes","volume":"303","author":"Phillips","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1002\/jps.20516_bb0090","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.1002\/jps.20163","article-title":"Avidin\/biotin-liposome system injected in pleural space for drug delivery to mediastinal lymph nodes","volume":"93","author":"Medina","year":"2004","journal-title":"J Pharm Sci"},{"key":"10.1002\/jps.20516_bb0095","first-page":"539","article-title":"A simple method for producing a technetium-99m-labeled liposome which is stable in vivo","volume":"19","author":"Phillips","year":"1992","journal-title":"Nucl Med Biol"},{"key":"10.1002\/jps.20516_bb0100","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1007\/BF00168879","article-title":"Active removal of radioactivity in the blood circulation using biotin-bearing liposomes and avidin for rapid tumour imaging","volume":"20","author":"Ogihara-Umeda","year":"1993","journal-title":"Eur J Nucl Med"},{"key":"10.1002\/jps.20516_bb0105","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/0003-2697(80)90269-9","article-title":"Colorimetric determination of phospholipids with ammonium ferrothiocyanate","volume":"104","author":"Stewart","year":"1980","journal-title":"Anal Biochem"},{"key":"10.1002\/jps.20516_bb0110","series-title":"Spectrophotometric determination of avidin and biotin. Advance in protein chemistry","first-page":"85","author":"Green","year":"1975"},{"key":"10.1002\/jps.20516_bb0115","first-page":"187","article-title":"Patent blue V encapsulation in liposomes: Potential applicability to endolymphatic therapy and preoperative chromolymphography","volume":"21","author":"Hirnle","year":"1988","journal-title":"Lymphology"},{"key":"10.1002\/jps.20516_bb0120","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1378\/chest.121.4.1177","article-title":"Assessment of lymph node tuberculosis in north Germany","volume":"121","author":"Geldmacher","year":"2002","journal-title":"Chest"},{"key":"10.1002\/jps.20516_bb0125","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1038\/modpathol.3880337","article-title":"Quantitative pathology of inhalational anthrax I: Quantitative microscopic findings","volume":"14","author":"Grinberg","year":"2001","journal-title":"Mod Pathol"},{"key":"10.1002\/jps.20516_bb0130","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/S0022-5223(19)34555-6","article-title":"Direct lymphatic drainage of lung segments to the mediastinal nodes","volume":"97","author":"Riquet","year":"1989","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1002\/jps.20516_bb0135","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/0169-409X(95)00045-9","article-title":"Targeting of colloids to lymph nodes: Influence of lymphatic physiology and colloidal charateristics","volume":"17","author":"Hawley","year":"1995","journal-title":"Adv Drug Delivery Rev"},{"key":"10.1002\/jps.20516_bb0140","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0169-409X(00)00121-6","article-title":"Lymphatic targeting with nanoparticulate system","volume":"47","author":"Nishioka","year":"2001","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1002\/jps.20516_bb0145","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/s00276-002-0081-y","article-title":"Lymphatic drainage of the diaphragmatic pleura to the peritracheobronchial lymph nodes","volume":"25","author":"Okiemy","year":"2003","journal-title":"Surg Radiol Anat"},{"key":"10.1002\/jps.20516_bb0150","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.2174\/1381612043383467","article-title":"Targeted liposomal drug delivery in cancer","volume":"10","author":"Medina","year":"2004","journal-title":"Current Pharm Design"},{"key":"10.1002\/jps.20516_bb0155","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1593\/neo.04538","article-title":"Integrin avb3-targeted imaging of lung cancer","volume":"7","author":"Chen","year":"2005","journal-title":"Neoplasia"},{"key":"10.1002\/jps.20516_bb0160","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1183\/09031936.98.11020492","article-title":"Respiratory muscles as a target for adenovirous-mediated gene therapy","volume":"11","author":"Petrof","year":"1998","journal-title":"Eur Respir J"},{"key":"10.1002\/jps.20516_bb0165","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0378-4274(00)00201-0","article-title":"Intraperitoneal administration of doxorubicin encapsulating lipsosomes against peritoneal dissemination","volume":"116","author":"Sadzuka","year":"2000","journal-title":"Toxicol Lett"},{"key":"10.1002\/jps.20516_bb0170","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1002\/jps.2600740902","article-title":"Lymphatic transport of liposome-encapsulated agents: Effects of liposome size following intraperitoneal administration","volume":"74","author":"Hirano","year":"1985","journal-title":"J Pharm Sci"},{"key":"10.1002\/jps.20516_bb0175","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1002\/(SICI)1097-0185(199709)249:1<16::AID-AR3>3.0.CO;2-D","article-title":"Distribution of lymphatic stomata on the pleural surface of the thoracic cavity and the surface topography of the pleural mesothelium in golden hamster","volume":"249","author":"Shinohara","year":"1997","journal-title":"Anat Rec"},{"key":"10.1002\/jps.20516_bb0180","first-page":"881","article-title":"Intralymphatic administration of liposome-encapsulated drugs to mice: Possibility for suppression of the growth of tumor metastases in the lymph nodes","volume":"66","author":"Kaledin","year":"1981","journal-title":"J Natl Cancer Inst"},{"key":"10.1002\/jps.20516_bb0185","first-page":"517","article-title":"Enhanced lymph node uptake of melphalan following liposomal entrapment and effects on lymph node metastasis in rats","volume":"66","author":"Khato","year":"1982","journal-title":"Cancer Treatment Reports"},{"key":"10.1002\/jps.20516_bb0190","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(01)00150-8","article-title":"The physiology of the lymphatic system","volume":"50","author":"Swartz","year":"2001","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1002\/jps.20516_bb0195","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0168-3659(02)00199-2","article-title":"Poly(ethylene glycol)-avidin bioconjugates: Suitable candidates for tumor pretargeting","volume":"83","author":"Caliceti","year":"2002","journal-title":"J Control Release"},{"key":"10.1002\/jps.20516_bb0200","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/bjc.1998.463","article-title":"Biochemical modifications of avidin improve pharmacokinetics and biodistribution, and reduce immunogenicity","volume":"78","author":"Chinol","year":"1998","journal-title":"Br J Cancer"},{"key":"10.1002\/jps.20516_bb0205","first-page":"410","article-title":"Reduction in immunogenicity and clarance rate of Escherichia coli 1-asparaginase by modification with monomethoxy-polyethylene glycol","volume":"216","author":"Kamisaki","year":"1981","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1002\/jps.20516_bb0210","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.4049\/jimmunol.144.1.209","article-title":"Immunogenicity of recombinant IL-2 modified by covalent attachment of polyethylene glycol","volume":"144","author":"Katre","year":"1990","journal-title":"Immunol J"},{"key":"10.1002\/jps.20516_bb0215","first-page":"4310","article-title":"Chemical engineering of the monoclonal antibody A7 by polyethylene glycol for targeting cancer chemotherapy","volume":"51","author":"Kitamura","year":"1991","journal-title":"Cancer Research"},{"key":"10.1002\/jps.20516_bb0220","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1038\/bjc.1995.186","article-title":"Molecular design of hybrid tumor necrosis factor alpha with polyethylene glycol increases its antitumor potency","volume":"71","author":"Tsutsumi","year":"1995","journal-title":"Br J Cancer"},{"key":"10.1002\/jps.20516_bb0225","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/bjc.1996.99","article-title":"Polyethylene glycol modification of a galactosylated streptavidin clearing agent: Effects on immunogenicity and clearance of biotinylated anti-tumor antibody","volume":"73","author":"Marshall","year":"1996","journal-title":"Br J Cancer"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354916319220?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354916319220?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,5]],"date-time":"2023-05-05T16:56:54Z","timestamp":1683305814000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354916319220"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,1]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,1]]}},"alternative-id":["S0022354916319220"],"URL":"https:\/\/doi.org\/10.1002\/jps.20516","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2006,1]]}}}